Auro Pharmacies Recalls Folic Acid Injectable Due to Sterility Concerns
Auro Pharmacies, Inc. is recalling 40 vials of Folic Acid injectable due to inadequate processes and equipment to assure sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable product, which poses a significant risk of serious injury or infection.
Plain-English summary
Auro Pharmacies, Inc. is recalling 40 vials of Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial. The product was compounded by Central Drugs Compounding Pharmacy in La Habra, California, and distributed nationwide in the USA. The specific lot number is 180611/1 with an expiration date of 09-Sep-18.
The recall was initiated because of a lack of assurance of sterility. The source text states that there were inadequate processes and equipment to assure the sterility of products intended to be sterile.
Consumers and healthcare providers should stop using the affected product and contact Auro Pharmacies, Inc. for further instructions or a refund.
The recalled product
- Product
- Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
- Manufacturer
- Auro Pharmacies, Inc.
- Category
- Drug — Injectable
- Affected units
- 40
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 180611/1
- Exp 09-Sep-18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by Auro Pharmacies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Auro Pharmacies, Inc.
See all →- SevereAuro Pharmacies Recalls Calcium Gluconate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Testosterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Methyl-Cobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Testosterone Enanthate/Cypionate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Glutathione Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereKey Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighFolic Acid Injectable Vials Recalled Due to Sterility Concerns
FDA (Drugs) · 2022-07-20
- SeverePromise Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereFolic Acid Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereAbbott's Compounding Pharmacy Recalls Folic Acid Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
- HighInjectable Folic Acid and Hydroxocobalamin Recalled Due to Sterility Concerns
FDA (Drugs) · 2022-06-01